alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 32.2





CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,


AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





In connection with the Annual Report of DC Brands International, Inc., a Colorado corporation (the “Company”), on Form 10-K for the period ended December 31, 2010 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Bob Armstrong, Chief Financial Officer of the Company, certify, pursuant to Section 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:





(1)
The Report fully complies with the requirements of Section 13(a) and 15(d) of the Securities Exchange Act of 1934; and





(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.




/s/ Bob ArmstrongChief Financial Officer(Principal Financial and Accounting Officer)March 31, 2011
```

[Congressional Bills 109th Congress]
[From the U.S. Government Publishing Office]
[S. 699 Introduced in Senate (IS)]

109th CONGRESS
  1st Session
                                 S. 699

        To suspend temporarily the duty on allyl ureido monomer.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             April 5, 2005

Mr. Lautenberg introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
        To suspend temporarily the duty on allyl ureido monomer.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. ALLYL UREIDO MONOMER.

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following new heading:

``      9902.06.02       2-                 Free         No change        No change        On or before 12/  ''.
                         Imidazolidinone,                                                   31/2007
                         1-(2-aminoethyl)-
                         , reaction
                         product with
                         oxirane, ((2-
                         propenyloxy)methy
                         l)- (CAS No.
                         90412-00-3)
                         (provided for in
                         subheading
                         2933.29.90)......

    (b) Effective Date.--The amendment made by subsection (a) applies 
to articles entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of the enactment of this Act.
                                 <all>
```
2011 Crystal Drive
Suite 800

[ N C B   L o g o ]
Arlington, Virginia 22202

TEL (703) 302-8000

March 3, 2008
TOLL (800) 955-9622
FAX (703) 647-3460

Morgan Stanley Capital I Inc. Attention: Compliance Manager 1585 Broadway New York, NY 10036
RE: Annual Statement as to Compliance
MSCI Series 2007-IQ13
Dear Sir/Madam:
In accordance with the Pooling and Servicing Agreement entered into in connection with the issuance of the Morgan Stanley Capital I Inc. Commercial Mortgage Pass-Through Certificates, Series 2007-IQ13, as an authorized officer of NCB, FSB (the "NCB Master Servicer"), I hereby certify that
a.

A review of  the activities of NCB Maser Servicer during the preceding calendar year and of its performance under the Pooling and Servicing Agreement has been made under my supervision.
b.

To the best of my knowledge, based on these reviews, the NCB Master Servicer has fulfilled all obligations under this Agreement in all material respects throughout the year.

NCB, FSB

By:
/s/ Michelle Connelly
Name:   Michelle Connelly Title:   Senior Vice President, Investor Compliance
Banking  & Financial Services

w w w . n c b . c o o p
Cooperative Expansion Economic Development
[Federal Register Volume 74, Number 94 (Monday, May 18, 2009)]
[Notices]
[Page 23193]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-11483]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Initial Review 
Group, Subcommittee J--Population and Patient-Oriented Training.
    Date: June 17, 2009.
    Time: 7:45 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Alexandria Old Town, 1767 King Street, Alexandria, 
VA 22314.
    Contact Person: Ilda M. Mckenna, PhD, Scientific Review Officer, 
Research Training Review Branch, Division of Extramural Activities, 
National Cancer Institute, 6116 Executive Boulevard, Room 8111, 
Bethesda, MD 20892. 301-496-7481. <a href="/cdn-cgi/l/email-protection#620f0109070c0c030b220f030b0e4c0c0b0a4c050d14"><span class="__cf_email__" data-cfemail="1c717f777972727d755c717d757032727574327b736a">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: May 11, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-11483 Filed 5-15-09; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Exhibit
32.1




CERTIFICATION
OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO


RULE
13A-14(B) OR RULE 15D-14(B)


OF
THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED, AND


18
U.S.C. SECTION 1350,


AS
ADOPTED PURSUANT TO SECTION 906


OF
THE SARBANES-OXLEY ACT OF 2002






In
connection with the annual report on Form 10-K of Consolidation Services, Inc.
(the “Company”) for the year ended December 31, 2008, as filed with the
Securities and Exchange Commission on the date hereof (the “Report”), I, Johnny
R. Thomas, Chief Executive Officer of the Company, hereby certify, pursuant to
18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that:




(a)
            The
      Report fully complies with the requirements of Section 13(a) or 15(d) of
      the Securities Exchange Act of 1934;
and




(b)
            The
      information contained in the Report fairly presents, in all material
      respects, the financial condition and results of operations of the
      Company.






Dated:
March 25, 2009


CONSOLIDATION
SERVICES, INC.






By:/s/ Johnny R.
Thomas


Johnny R.
Thomas


Chief
Executive Officer




A signed
original of this written statement required by Section 906, or other document
authenticating, acknowledging or otherwise adopting the signature that appears
in typed form within the electronic version of this written statement required
by Section 906, has been provided to Consolidation Services, Inc. and will be
retained by Consolidation Services, Inc. and furnished to the Securities and
Exchange Commission or its staff upon request.
Exhibit
99.4








CERTIFICATE
PURSUANT TO


18 U.S.C.
SECTION 1350


AS
ADOPTED PURSUANT TO


SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002








In
connection with the Annual Report (the “Report”) on the Form 10K of Sona
Resources, Inc. (the “Company”) for the year ended September 30, 2008, as filed
with the Securities and Exchange Commission on the date hereof, I, Monika Sagar,
Chief Accounting Officer, Chief Financial Officer and Director, certify,
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and
belief:





1.    The
Report fully complies with the requirements of Section 13 (a) or 15 (d) of the
Securities and Exchange Act of 1934, as amended; and





2.     The
information contained in this Report fairly presents, in all material respects,
the financial condition and results of operation of the Company.








November
20, 2008                 MONIKA
SAGAR


Monika Sagar


Chief
Accounting Officer, Chief Financial Officer and Director

















-1-
<PAGE>

                                                                    EXHIBIT 32.2


                           SECTION 1350 CERTIFICATION

         In connection with the Annual Report of Allied Healthcare International
Inc. (the "Company") on Form 10-K for the period ending September 30, 2003, as
filed with the Securities and Exchange Commission on the date hereof (the
"Report"), I, Charles F. Murphy, Acting Chief Financial Officer of the Company,
certify, pursuant to 18. U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the
Sarbanes-Oxley Act of 2002, that:

         (1) The Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

         (2) The information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company as at and for the year ended September 30, 2003.

Dated:  December 29, 2003


                                    /s/ Charles F. Murphy
                                   ---------------------------------------------
                                   Charles F. Murphy
                                   Acting Chief Financial Officer of the Company
```

[Congressional Bills 109th Congress]
[From the U.S. Government Publishing Office]
[S. 4062 Introduced in Senate (IS)]

109th CONGRESS
  2d Session
                                S. 4062

To freeze non-defense discretionary spending at fiscal year 2007 levels 
                     effective in fiscal year 2008.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                           November 16, 2006

  Mr. Inhofe introduced the following bill; which was read twice and 
                referred to the Committee on the Budget

_______________________________________________________________________

                                 A BILL

To freeze non-defense discretionary spending at fiscal year 2007 levels 
                     effective in fiscal year 2008.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Fiscal Responsibility Act of 2006''.

SEC. 2. CONGRESSIONAL ENFORCEMENT.

    (a) Enforcement.--Section 312 of the Congressional Budget Act of 
1974 (2 U.S.C. 643) is amended by adding at the end the following:
    ``(g) Excess Non-Defense Discretionary Federal Spending Reduction 
Point of Order.--
            ``(1) In general.--It shall not be in order in the House of 
        Representatives or the Senate to consider any bill or 
        resolution (or amendment, motion, or conference report on that 
        bill or resolution) that would cause spending for non-defense, 
        non-trust-fund, discretionary spending for the budget year to 
        exceed the amount of spending for such activities in fiscal 
        year 2007.
            ``(2) Allocations.--The allocations under section 302(a) 
        shall include allocations for the amount described in paragraph 
        (1).
            ``(3) Super majority waiver or appeal.--This subsection may 
        be waived or suspended in the Senate only by an affirmative 
        vote of two-thirds of the Members, duly chosen and sworn. An 
        affirmative vote of two-thirds of the Members of the Senate, 
        duly chosen and sworn, shall be required in the Senate to 
        sustain an appeal of the ruling of the Chair on a point of 
        order raised under this subsection.''.
    (b) Effective Date.--This section shall apply beginning with fiscal 
year 2008.
                                 <all>
```
##### 



Exhibit 12 COMPUTATION OF RATIO OF INCOME TO COMBINED FIXED CHARGES SEARS, ROEBUCK AND CO. AND CONSOLIDATED SUBSIDIARIES
 SixMonths
    
    
    Year EndedEnded6/28/03(millions, except ratios)
    
    (unaudited)
    
    
    2002
    
    
    2001
    
    
    2000
    
    
    1999
    
    
    1998Fixed ChargesInterest and amortization of debt discount
and expense on all indebtedness
    
    $
    566
    
    
    $
    1,143
    
    
    $
    1,415
    
    
    $
    1,248
    
    
    $
    1,268
    
    
    $
    1,423Add interest element implicit in rentals
    
    $
    76
    
    
    
    157
    
    
    
    161
    
    
    
    136
    
    
    
    133
    
    
    
    144$
    642
    
    
    
    1,300
    
    
    
    1,576
    
    
    
    1,384
    
    
    
    1,401
    
    
    
    1,567Interest capitalized
    
    $
    1
    
    
    
    4
    
    
    
    11
    
    
    
    4
    
    
    
    5
    
    
    
    5Total fixed charges
    
    $
    643
    
    
    $
    1,303
    
    
    $
    1,587
    
    
    $
    1,388
    
    
    $
    1,406
    
    
    $
    1,572IncomeIncome (loss) before income taxes,
minority interest, and extraordinary loss
    
    $
    812
    
    
    $
    2,453
    
    
    $
    1,223
    
    
    $
    2,223
    
    
    $
    2,419
    
    
    $
    1,883Deduct undistributed net income (loss)
of unconsolidated companies
    
    $
    4
    
    
    
    20
    
    
    
    12
    
    
    
    17
    
    
    
    (5
    )
    
    
    11$
    808
    
    
    
    2,433
    
    
    
    1,211
    
    
    
    2,206
    
    
    
    2,424
    
    
    
    1,872AddFixed charges (excluding interest capitalized)
    
    $
    643
    
    
    
    1,300
    
    
    
    1,576
    
    
    
    1,384
    
    
    
    1,401
    
    
    
    1,567Income before fixed charges and
income taxes
    
    $
    1,451
    
    
    $
    3,733
    
    
    $
    2,787
    
    
    $
    3,590
    
    
    $
    3,825
    
    
    $
    3,439Ratio of income to fixed charges
    
    
    2.26
    
    
    
    2.86
    
    
    
    1.76
    
    
    
    2.59
    
    
    
    2.72
    
    
    
    2.19
UNPUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT No. 01-6660

TYRONE HOLLEY, Petitioner - Appellant, versus THEODIS BECK, Respondent - Appellee.Appeal from the United States District Court for the Middle District of North Carolina, at Durham. N. Carlton Tilley, Jr., Chief District Judge. (CA-00-567-1) Submitted: August 23, 2001 Decided: August 30, 2001 Before WILKINS and KING, Circuit Judges, and HAMILTON, Senior Circuit Judge. Dismissed by unpublished per curiam opinion. Tyrone Holley, Appellant Pro Se. Clarence Joe DelForge, III, OFFICE OF THE ATTORNEY GENERAL OF NORTH CAROLINA, Raleigh, North Carolina, for Appellee. Unpublished opinions are not binding precedent in this circuit. See Local Rule 36(c).2 PER CURIAM: Tyrone Holley appeals the district court’s order denying relief on his petition filed under 28 U.S.C.A. § 2254 (West 1994 & Supp. 2001). We have reviewed the record and the district court’s opinion accepting the recommendation of the magistrate judge and find no reversible error. Accordingly, we deny a certificate of appealability and dismiss the appeal on the reasoning of the district court. Holley v. Beck , No. CA-00-567-1 (M.D.N.C. filed Mar. 26, 2001; entered Mar. 27, 2001). We decline to consider the claims that Holley asserts for the first time on appeal. See Muth v. United States , 1 F.3d 246, 250 (4th Cir. 1993). We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

DISMISSED
Exhibit 10.2

[California Bank & Trust]

June 9, 2010

Marty McDermut

Chief Financial Officer

IRIS International,
Inc.

9172 Eton Avenue

Chatsworth,
CA 91311



|Re: | 60  Day Extension to the RLOC
|--- | ------------------------------

Dear
Marty;

Reference is made to that certain Business Loan Agreements dated as of March 24, 2006 for the revolving line of credit entered
into between IRIS International, Inc. (Company) and California Bank & Trust (Bank), together with any and all amendments, modifications, restated loan agreements, and riders (collectively, the Revolving Loan
Agreement) governing certain terms and conditions therein.

Bank hereby extends the maturity of the Revolving Loan Agreement to
August 31, 2010.

Please give me a call if you have any questions regarding this matter.



|              
|--------------
|Sincerely,    
|              
|/s/ Joe Lim   
|Joe Lim       
|Vice President
#### In the Matter of H.M., Appellant, v E.T., Respondent.

Submitted January 4, 2010;

decided January 12, 2010

Reported below, 65 AD3d 119.

Motion by New York County Lawyers’ Association for leave to appear amicus curiae on the appeal herein granted only to the extent that the proposed brief is accepted as filed.
**EXHIBIT 31.2**
**CERTIFICATION**
I, WILLIAM R. KERR, certify that:
1. I have reviewed this quarterly report on Form 10-Q for the second quarter of 2004 of NortelNetworks Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material factor omit to state a material fact necessary to make the statements made, in light of thecircumstances under which such statements were made, not misleading with respect to the periodcovered by this report; 3. Based on my knowledge, the financial statements, and other financial information included inthis report, fairly present in all material respects the financial condition, results ofoperations and cash flows of the registrant as of, and for, the periods presented in thisreport; 4. The registrant’s other certifying officer and I are responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and15d-15(e)) for the registrant and have:
 (a) Designed such disclosure controls and procedures, or caused such disclosurecontrols and procedures to be designed under our supervision, to ensure that materialinformation relating to the registrant, including its consolidated subsidiaries, ismade known to us by others within those entities, particularly during the period inwhich this report is being prepared;  (b) Evaluated the effectiveness of the registrant’s disclosure controls andprocedures and presented in this report our conclusions about the effectiveness of thedisclosure controls and procedures, as of the end of the period covered by this reportbased on such evaluation; and  (c) Disclosed in this report any change in the registrant’s internal control overfinancial reporting that occurred during the registrant’s most recent fiscal quarter(the registrant’s fourth fiscal quarter in the case of an annual report) that hasmaterially affected, or is reasonably likely to materially affect, the registrant’sinternal control over financial reporting.
5. The registrant’s other certifying officer and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the registrant’s auditors and theaudit committee of the registrant’s board of directors (or persons performing the equivalentfunctions):
 (a) All significant deficiencies and material weaknesses in the design or operationof internal control over financial reporting which are reasonably likely to adverselyaffect the registrant’s ability to record, process, summarize and report financialinformation; and  (b) Any fraud, whether or not material, that involves management or other employeeswho have a significant role in the registrant’s internal control over financialreporting.
Date: January 31, 2005
/s/ WILLIAM R. KERRWILLIAM R. KERR
EXHIBIT 31.1
 Certification Required by Rule 13a-14(a) or Rule 15d-14(a)
      a)
    
    designed such disclosure controls and procedures, or caused such disclosure controls
and procedures to be designed under my supervision, to ensure that material information
relating to the registrant, including its consolidated subsidiaries, is made known to me by
others within those entities, particularly during the period in which this report is being
prepared;b)
    
    designed such internal control over financial reporting, or caused such internal
control over financial reporting to be designed under my supervision, to provide reasonable
assurance regarding the reliability of financial reporting and the preparation of financial
statements for external purposes;c)
    
    evaluated the effectiveness of the registrants disclosure controls and procedures and
presented in this report my conclusions about the effectiveness of the disclosure controls
and procedures, as of the end of the period covered by this report based on such
evaluation;d)
    
    disclosed in this report any change in the registrants internal control over financial
reporting that occurred during the registrants most recent fiscal quarter (the
registrants fourth fiscal quarter in




---



##### 



the case of an annual report) that has materially affected, or is reasonably likely to
materially affect, the registrants internal control over financial reporting; and
  a)
    
    all significant deficiencies and material weaknesses in the design or operation of
internal control over financial reporting which are reasonably likely to adversely affect
the registrants ability to record, process, summarize and report financial information;
andb)
    
    any fraud, whether or not material, that involves management or other employees who
have a significant role in the registrants internal control over financial reporting.
  Date:  May 9, 2011
    By:
    /s/ RON E. HOOPERRon E. Hooper,Senior Vice President and Trust Administrator
Bank of America, N.A. 2
#### Helmsley-Spear, Inc., et al., Respondents, v Michael Fishman, as President of SEIU, et al., Appellants.

Submitted October 5, 2009;

decided December 1, 2009

Reported below, 57 AD3d 455.

Motion for leave to appeal dismissed upon the ground that the order sought to be appealed from does not finally determine the action within the meaning of the Constitution.